http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0154220-A3
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 |
| filingDate | 1985-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1986-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0154220-A3 |
| titleOfInvention | Pyrazolopyridine derivatives |
| abstract | Compounds of formula (I) and pharmaceutically acceptnble salts thereof: n nwherein: nX is NR wherein R is hydrogen or C₁₋₆ alkyl, oxygen, nsulphur, SO or SO₂; nR₁ is COR₅ wherein R₅ is hydroxy, or COR₅ is a npharmaceutically acceptable ester or amide group; or CF₃; nand R₂ is hydrogen, C₁₋₆ alkyl or phenyl optionally substintuted by halogen, CF₃, C₁₋₄ alkoxy or C₁₋₄ alkyl; or R₂ is COR₅ nas defined or CF₃ and R₁ is hydrogen; nR₃ is C₁₋₁₀ alkyl, optionally substituted by hydroxy, C₁₋₄ nalkoxy, thiol, C₁₋₄ alkylthio or NR₆R₇ herein R₆ and R₇ are nindependently hydrogen or C₁₋₆ alkyl or together are C₃₋₆ npolymethlene; C₂₋₁₀ alkenyl or phenyl optionally substituted nby one or two of halogen, CF₃, C₁₋₄ alkoxy, C₁₋₄ alkyl, nhydroxy, nitro, cyano, C₂₋₁₀ acyloxy, NR₈R₉ wherein R₈ and nR₉ are independently selected from hydrogen, C₁₋₆ alkyl, C₂₋₇ nalkanoyl or C₁₋₆ alkylsulphonyl or COR₁₀ wherein R₁₀ is nhydroxy, C₁₋₆ alkoxy or NR₁₁R₁₂ wherein R11 and R₁₂ are nindependently selected from hydrogen or C₁₋₆ alkyl; and nR₄ is hydrogen: or C₁₋₄ alkyl or benzyl attached at nnitrogen atom 1 or 2 having anti-inflammatory and/or nanti-allergy activity, a process for their preparation and their nuse as pharmaceuticals. |
| priorityDate | 1984-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 85.